The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today read about a new 3-in-1 blood test for prostate cancer, our chromatography appeal and a test that can pick out men at increased risk of testicular cancer.
Dr Sebastian Guettler has been awarded a Lister Institute Research Prize Fellowship, recognising him as one of the UK's most promising young biomedical researchers.
Researchers have found seven new single-letter changes to DNA that are linked to an increased chance of developing renal cell carcinoma.
In this Science Talk blog post we share our excitement about the potential that structural biology has to enable the discovery of brand new cancer drugs
Join #teamICR for the Royal Parks Foundation Half Marathon 2017 and help us defeat cancer.
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer.
To achieve our aims, we need to put down strong foundations in the way we organise and support our research.
We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Help support our new programme of research into hormone receptor-positive breast cancer
For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
Find out how we plan to educate and train the next generation of cancer researchers and clinicians.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
Five reasons we’re excited by how structural biology is advancing cancer research
Tribute to Patrick (Paddy) Johnston – a true leader and champion of cancer research and cancer patients
#ICRjobs Deputy Director of Development (Philanthropy)
Deadline: 5 July
#ICRprofile Professor Julian Downward's work is improving the early detection of #lungcancer https://t.co/meyCxLqwLO https://t.co/gmkRg8mYBK
Our research featured in @MailOnline today — Will NHS approve new cancer drug which avoids pain of chemotherapy?… https://t.co/JspACT7IrG